U.S. Pharmaceuticals & Biotech Strong Balance Sheet Stocks

Context Therapeutics

Market Cap: US$64.6m

A biopharmaceutical company, develops products for the treatment of solid tumors.

RenovoRx

Market Cap: US$41.7m

A clinical-stage biopharmaceutical company, engages in the developing of targeted combination therapies to enhance therapeutic outcomes for cancer patients undergoing treatment.

PharmaCyte Biotech

Market Cap: US$5.7m

A biotechnology company, develops and commercializes cellular therapies for cancer in the United States.

InMed Pharmaceuticals

Market Cap: US$2.7m

A clinical stage pharmaceutical company, develops a pipeline of prescription-based products in the United States.

Stevanato Group

Market Cap: US$6.5b

Engages in the design, production, and distribution of products and processes to provide solutions for biopharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific.

Silence Therapeutics

Market Cap: US$238.0m

A biotechnology company, engages in the discovery and development of novel molecules incorporating short interfering ribonucleic acid (siRNA) to inhibit the expression of specific target genes in hematology, cardiovascular, and rare diseases.

Niagen Bioscience

Market Cap: US$777.6m

Operates as a bioscience company engages in developing healthy aging products.

Biogen

Market Cap: US$19.2b

Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases in the United States, Europe, Germany, Asia, and internationally.

Anbio Biotechnology

Market Cap: US$2.2b

Provides in vitro diagnostics (IVD) products in the European Union, the Asia Pacific, North America, South America, Africa, and internationally.

Bone Biologics

Market Cap: US$3.7m

A medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein.

Trevi Therapeutics

Market Cap: US$903.6m

A clinical-stage biopharmaceutical company, focuses on the development and commercialization of investigational therapy for the treatment of chronic cough in patients with idiopathic pulmonary fibrosis (IPF) and non-IPF interstitial lung disease, and refractory chronic cough.

Passage Bio

Market Cap: US$19.6m

A genetic medicines company, develops gene therapies for central nervous system diseases.

Corcept Therapeutics

Market Cap: US$7.6b

Engages in discovery and development of medication for the treatment of severe endocrinologic, oncologic, metabolic, and neurologic disorders in the United States.

ACADIA Pharmaceuticals

Market Cap: US$4.2b

A biopharmaceutical company, focuses on the development and commercialization of medicines for central nervous system (CNS) disorders and rare diseases in the United States.

Exelixis

Market Cap: US$10.2b

An oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States.

ADMA Biologics

Market Cap: US$3.9b

A biopharmaceutical company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally.

Boundless Bio

Market Cap: US$24.2m

A clinical-stage oncology company, develops cancer therapeutics to address the unmet need of patients with oncogene amplified tumors by interrogating extrachromosomal DNA (ecDNA).

Astria Therapeutics

Market Cap: US$354.4m

A biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics for allergic and immunological diseases in the United States.

MEI Pharma

Market Cap: US$168.0m

A clinical-stage pharmaceutical company, focuses on the development of various therapies for the treatment of cancer.

Ventyx Biosciences

Market Cap: US$200.0m

A clinical-stage biopharmaceutical company, develops oral therapies for patients with autoimmune, inflammatory, and neurodegenerative diseases.

Lineage Cell Therapeutics

Market Cap: US$224.8m

A clinical-stage biotechnology company, develops novel cell therapies for neurological and ophthalmic conditions in the United States and internationally.

Protara Therapeutics

Market Cap: US$120.8m

A clinical-stage biopharmaceutical company, engages in advancing transformative therapies for the treatment of cancer and rare diseases.

Lantern Pharma

Market Cap: US$53.8m

Focuses on the discovery and development of oncology drug.

China SXT Pharmaceuticals

Market Cap: US$184.5m

A pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China.

Atossa Therapeutics

Market Cap: US$101.7m

Operates as a clinical-stage biopharmaceutical company that develops medicines in the areas of unmet medical need in oncology for women breast cancer and other conditions in the United States.

OS Therapies

Market Cap: US$57.8m

A clinical stage biopharmaceutical company, focuses on the identification, development, and commercialization of treatments for osteosarcoma and other solid tumors in the United States.

Qiagen

Market Cap: US$10.4b

Provides sample to insight solutions that transform biological samples into molecular insights in the Netherlands and internationally.

Tourmaline Bio

Market Cap: US$532.3m

Operates as a clinical biotechnology company that develops medicines for patients with life-altering immune and inflammatory diseases.

ProKidney

Market Cap: US$758.1m

A clinical-stage biotechnology company, develops a cell therapy platform for the treatment of multiple chronic kidney diseases in the United States.

GH Research

Market Cap: US$769.8m

Together with its subsidiary, a clinical-stage biopharmaceutical company, engages in developing treatments for depression in the United States.

Aldeyra Therapeutics

Market Cap: US$315.1m

A biotechnology company, discovers and develops therapies designed to treat immune-mediated and metabolic diseases.

ImmunoPrecise Antibodies

Market Cap: US$92.3m

Operates as an AI-driven biotherapeutic research, technology, and scientifically robust life science company.

Vaxcyte

Market Cap: US$3.9b

A clinical-stage vaccine innovation company, develops conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases.

Pacira BioSciences

Market Cap: US$1.1b

Engages in the development, manufacture, marketing, distribution, and sale of non-opioid pain management and regenerative health solutions to healthcare practitioners in the United States.

Intellia Therapeutics

Market Cap: US$1.2b

A clinical-stage gene editing company, focuses on the development of curative genome editing treatments.

Nurix Therapeutics

Market Cap: US$752.3m

A clinical stage biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule and antibody therapies for the treatment of cancer, inflammatory conditions, and other diseases.